[Experience with protocol T10 in the pediatric service at the Gustave-Roussy Institute]. 1988

C Kalifa, and N Mlika, and J Dubousset, and G Contesso, and D Vanel, and J Lumbroso
Service de pédiatrie, Institut Gustave-Roussy, Villejuif, France.

Between April and September 1986, 60 patients with osteosarcoma have been treated according to the T10 protocol in the Pediatrics Department of the Gustave Roussy Institute in Villejuif, France. Limb sparing could be achieved in 49 patients and amputation was necessary in 11. The necrosis of the primary tumor was total or subtotal in 33 cases and incomplete in the 27 others. With a median follow-up of 28 months, the actuarial survival is 85% at 48 months and the actuarial disease-free survival is 58%; the disease-free survival of "good responders" is 75% and 32% for "bad responders".

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D001761 Bleomycin A complex of related glycopeptide antibiotics from Streptomyces verticillus consisting of bleomycin A2 and B2. It inhibits DNA metabolism and is used as an antineoplastic, especially for solid tumors. BLEO-cell,Blanoxan,Blenoxane,Bleolem,Bleomicina,Bleomycin A(2),Bleomycin A2,Bleomycin B(2),Bleomycin B2,Bleomycin Sulfate,Bleomycins,Bleomycinum Mack,Bléomycine Bellon,BLEO cell,BLEOcell,Bellon, Bléomycine,Mack, Bleomycinum,Sulfate, Bleomycin
D001859 Bone Neoplasms Tumors or cancer located in bone tissue or specific BONES. Bone Cancer,Cancer of Bone,Cancer of the Bone,Neoplasms, Bone,Bone Neoplasm,Neoplasm, Bone
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal

Related Publications

C Kalifa, and N Mlika, and J Dubousset, and G Contesso, and D Vanel, and J Lumbroso
January 1994, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer,
C Kalifa, and N Mlika, and J Dubousset, and G Contesso, and D Vanel, and J Lumbroso
April 1969, Revue de l'infirmiere et de l'assistante sociale,
C Kalifa, and N Mlika, and J Dubousset, and G Contesso, and D Vanel, and J Lumbroso
April 1953, Minerva medica,
C Kalifa, and N Mlika, and J Dubousset, and G Contesso, and D Vanel, and J Lumbroso
August 1998, Cancer,
C Kalifa, and N Mlika, and J Dubousset, and G Contesso, and D Vanel, and J Lumbroso
January 1993, Cancer treatment and research,
C Kalifa, and N Mlika, and J Dubousset, and G Contesso, and D Vanel, and J Lumbroso
January 1956, La Lutte contre le cancer,
C Kalifa, and N Mlika, and J Dubousset, and G Contesso, and D Vanel, and J Lumbroso
January 1992, Bulletin du cancer,
C Kalifa, and N Mlika, and J Dubousset, and G Contesso, and D Vanel, and J Lumbroso
April 1951, Gazette medicale de France,
C Kalifa, and N Mlika, and J Dubousset, and G Contesso, and D Vanel, and J Lumbroso
January 1985, Annales de pathologie,
C Kalifa, and N Mlika, and J Dubousset, and G Contesso, and D Vanel, and J Lumbroso
January 1970, Revue de stomatologie et de chirurgie maxillo-faciale,
Copied contents to your clipboard!